ESPERVITA THERAPEUTICS

Serial Number 88300521
602

Registration Progress

Application Filed
Feb 13, 2019
Under Examination
Aug 13, 2019
Approved for Publication
Jun 18, 2019
Published for Opposition
Jun 18, 2019
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ESPERVITA THERAPEUTICS
Previous Owner: Espervita Therapeutics, Inc.
Classes: 005

Trademark Image

ESPERVITA THERAPEUTICS

Basic Information

Serial Number
88300521
Filing Date
February 13, 2019
Published for Opposition
June 18, 2019
Abandonment Date
March 1, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Mar 14, 2023
Classes
005

Rights Holder

Espervita Therapeutics, Inc.

03
Address
7939 Secretariat Drive
Saline, MI 48176

Ownership History

Espervita Therapeutics, Inc.

Original Applicant
03
Saline, MI

Espervita Therapeutics, Inc.

Owner at Publication
03
Saline, MI

Legal Representation

Attorney
Daniel Heaton

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

43 events
Date Code Type Description Documents
Mar 14, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Mar 14, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Mar 14, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Aug 31, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 31, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
Aug 31, 2022 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Aug 17, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 13, 2022 IUAF S USE AMENDMENT FILED Loading...
Aug 13, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 18, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Feb 11, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Feb 18, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 11, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 13, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 11, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 11, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 11, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 12, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 12, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 12, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 12, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 10, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 10, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 10, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 11, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 7, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 7, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 7, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 13, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 18, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 18, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 29, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 13, 2019 ALIE A ASSIGNED TO LIE Loading...
Apr 25, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 25, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 25, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 25, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 25, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 24, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 7, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 16, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
A full line of medicated and pharmaceutical preparations, both prescription and over-the-counter, pertaining to metabolic disease and oncology
First Use Anywhere: Jul 1, 2018
First Use in Commerce: Oct 1, 2018

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"